Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and prognosis

V. Kouranos (London, United Kingdom), S. Ward (London, United Kingdom), M. Kokosi (London, United Kingdom), S. Thomas (London, United Kingdom), D. Castillo (London, United Kingdom), E. Judge (London, United Kingdom), F. Van Tonder (London, United Kingdom), A. Devaraj (London, United Kingdom), T. Maher (London, United Kingdom), E. Renzoni (London, United Kingdom), A. Wells (London, United Kingdom)

Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Session: Sarcoidosis: from basic research to patient outcomes
Session type: Poster Discussion
Number: 5210
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Kouranos (London, United Kingdom), S. Ward (London, United Kingdom), M. Kokosi (London, United Kingdom), S. Thomas (London, United Kingdom), D. Castillo (London, United Kingdom), E. Judge (London, United Kingdom), F. Van Tonder (London, United Kingdom), A. Devaraj (London, United Kingdom), T. Maher (London, United Kingdom), E. Renzoni (London, United Kingdom), A. Wells (London, United Kingdom). Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and prognosis. 5210

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis
Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020
Year: 2021



Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
Source: Eur Respir J 2011; 37: 176-183
Year: 2011



Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

‘Idiopathic‘ pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival
Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Year: 2012

Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Severe pulmonary hypertension in patients with emphysema but preserved FEV1: Prognosis and response to treatment
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012



Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia
Source: Eur Respir J, 52 (1) 1800545; 10.1183/13993003.00545-2018
Year: 2018



Early diagnosis of invasive pulmonary aspergillus in patients with chronic obstructive pulmonary diseases: a case control study
Source: International Congress 2019 – Airway infection in COPD
Year: 2019


Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Prognosis of pulmonary sarcoidosis in young patients
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003

Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002

A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Sarcopenia in idiopathic pulmonary fibrosis (IPF): Prevalence and response to pulmonary rehabilitation (PR)
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020

Interstitial lung diseases in childhood
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=213
Year: 2002